{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T21:08:28Z","timestamp":1785186508031,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T00:00:00Z","timestamp":1705104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T00:00:00Z","timestamp":1705104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"We didn\u2019t receive grant for this research.","award":["We didn\u2019t receive grant for this research."],"award-info":[{"award-number":["We didn\u2019t receive grant for this research."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11033-023-09059-z","type":"journal-article","created":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T14:01:43Z","timestamp":1705154503000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["siRNA-mediated downregulation of BATF3 diminished proliferation and induced apoptosis through downregulating c-Myc expression in chronic myelogenous leukemia cells"],"prefix":"10.1007","volume":"51","author":[{"given":"Reza","family":"Dabbaghipour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Khaze Shahgoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Safaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Amini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SMB","family":"Tabei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariush","family":"Shanehbandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid","family":"Rahbar Farzam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8642-6795","authenticated-orcid":false,"given":"Behzad","family":"Baradaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Entezam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,13]]},"reference":[{"issue":"2","key":"9059_CR1","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00277-015-2325-z","volume":"94","author":"B Chereda","year":"2015","unstructured":"Chereda B, Melo JV (2015) Natural course and biology of CML. Ann Hematol 94(2):107\u2013121","journal-title":"Ann Hematol"},{"issue":"5","key":"9059_CR2","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0002-9343(96)00061-7","volume":"100","author":"JE Cortes","year":"1996","unstructured":"Cortes JE, Talpaz M, Kantarjian H (1996) Chronic myelogenous leukemia: a review. Am J Med 100(5):555\u2013570","journal-title":"Am J Med"},{"issue":"3","key":"9059_CR3","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/ajh.25011","volume":"93","author":"E Jabbour","year":"2018","unstructured":"Jabbour E, Kantarjian H (2018) Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring. Am J Hematol 93(3):442\u2013459","journal-title":"Am J Hematol"},{"issue":"1","key":"9059_CR4","first-page":"1","volume":"49","author":"E Alada\u011f","year":"2019","unstructured":"Alada\u011f E, Haznedaro\u011flu \u0130C (2019) Current perspectives for the treatment of chronic myeloid leukemia. Turk J Med Sci 49(1):1\u201310","journal-title":"Turk J Med Sci"},{"issue":"1","key":"9059_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13402-016-0297-1","volume":"40","author":"A Chavez-Gonzalez","year":"2017","unstructured":"Chavez-Gonzalez A, Bakhshinejad B, Pakravan K, Guzman ML, Babashah S (2017) Novel strategies for targeting leukemia stem cells: sounding the death knell for blood cancer. Cell Oncol 40(1):1\u201320","journal-title":"Cell Oncol"},{"issue":"6","key":"9059_CR6","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/ajh.25792","volume":"95","author":"E Jabbour","year":"2020","unstructured":"Jabbour E, Kantarjian H (2020) Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring. Am J Hematol 95(6):691\u2013709","journal-title":"Am J Hematol"},{"issue":"5","key":"9059_CR7","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.hoc.2011.09.004","volume":"25","author":"E Jabbour","year":"2011","unstructured":"Jabbour E, Parikh SA, Kantarjian H, Cortes J (2011) Chronic myeloid leukemia: mechanisms of resistance and treatment. Hematol Oncol Clin North Am 25(5):981","journal-title":"Hematol Oncol Clin North Am"},{"issue":"2","key":"9059_CR8","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3390\/cancers14020290","volume":"14","author":"I Hashimoto","year":"2022","unstructured":"Hashimoto I, Oshima T (2022) Claudins and gastric cancer: an overview. Cancers 14(2):290","journal-title":"Cancers"},{"issue":"1","key":"9059_CR9","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.0105-2896.2005.00332.x","volume":"208","author":"EF Wagner","year":"2005","unstructured":"Wagner EF, Eferl R (2005) Fos\/AP-1 proteins in bone and the immune system. Immunol Rev 208(1):126\u2013140","journal-title":"Immunol Rev"},{"issue":"11","key":"9059_CR10","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/nrc1209","volume":"3","author":"R Eferl","year":"2003","unstructured":"Eferl R, Wagner EF (2003) AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 3(11):859\u2013868","journal-title":"Nat Rev Cancer"},{"issue":"14","key":"9059_CR11","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1038\/sj.onc.1203491","volume":"19","author":"DR Echlin","year":"2000","unstructured":"Echlin DR, Tae H-J, Mitin N, Taparowsky EJ (2000) B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos. Oncogene 19(14):1752\u20131763","journal-title":"Oncogene"},{"issue":"7","key":"9059_CR12","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nri3470","volume":"13","author":"TL Murphy","year":"2013","unstructured":"Murphy TL, Tussiwand R, Murphy KM (2013) Specificity through cooperation: BATF\u2013IRF interactions control immune-regulatory networks. Nat Rev Immunol 13(7):499\u2013509","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"9059_CR13","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.3390\/diagnostics11061123","volume":"11","author":"J Benckendorff","year":"2021","unstructured":"Benckendorff J, Kuchar J, Leith\u00e4user F, Zahn M, M\u00f6ller P (2021) Usefulness of BATF3 immunohistochemistry in diagnosing classical Hodgkin Lymphoma. Diagnostics 11(6):1123","journal-title":"Diagnostics"},{"issue":"1","key":"9059_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1186\/s13287-021-02659-1","volume":"12","author":"H Mojtahedi","year":"2021","unstructured":"Mojtahedi H, Yazdanpanah N, Rezaei N (2021) Chronic myeloid leukemia stem cells: targeting therapeutic implications. Stem Cell Res Ther 12(1):603","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"9059_CR15","doi-asserted-by":"publisher","first-page":"333","DOI":"10.2174\/1389557518666181017124854","volume":"19","author":"VK Singh","year":"2019","unstructured":"Singh VK, Coumar MS (2019) Chronic myeloid leukemia: existing therapeutic options and strategies to Overcome Drug Resistance. Mini Rev Med Chem 19(4):333\u2013345","journal-title":"Mini Rev Med Chem"},{"issue":"7","key":"9059_CR16","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.drudis.2019.05.007","volume":"24","author":"DN Meenakshi Sundaram","year":"2019","unstructured":"Meenakshi Sundaram DN, Jiang X, Brandwein JM, Valencia-Serna J, Remant KC, Uluda\u011f H (2019) Current outlook on drug resistance in chronic myeloid leukemia (CML) and potential therapeutic options. Drug Discovery Today 24(7):1355\u20131369","journal-title":"Drug Discovery Today"},{"key":"9059_CR17","first-page":"67","volume":"13","author":"G Dessie","year":"2020","unstructured":"Dessie G, Derbew Molla M, Shibabaw T, Ayelign B (2020) Role of stem-cell transplantation in leukemia treatment. Stem Cell Cloning 13:67\u201377","journal-title":"Stem Cell Cloning"},{"issue":"5904","key":"9059_CR18","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1126\/science.1164206","volume":"322","author":"K Hildner","year":"2008","unstructured":"Hildner K, Edelson BT, Purtha WE, Diamond M, Matsushita H, Kohyama M et al (2008) Batf3 deficiency reveals a critical role for CD8alpha + dendritic cells in cytotoxic T cell immunity. Science 322(5904):1097\u20131100","journal-title":"Science"},{"issue":"7421","key":"9059_CR19","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/nature11531","volume":"490","author":"R Tussiwand","year":"2012","unstructured":"Tussiwand R, Lee WL, Murphy TL, Mashayekhi M, Kc W, Albring JC et al (2012) Compensatory dendritic cell development mediated by BATF-IRF interactions. Nature 490(7421):502\u2013507","journal-title":"Nature"},{"issue":"1","key":"9059_CR20","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13046-018-0757-8","volume":"37","author":"L Cao","year":"2018","unstructured":"Cao L, Liu Y, Wang D, Huang L, Li F, Liu J et al (2018) MiR-760 suppresses human Colorectal cancer growth by targeting BATF3\/AP-1\/cyclinD1 signaling. J Exp Clin Cancer Res 37(1):83","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"9059_CR21","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41417-020-00223-2","volume":"28","author":"P Li","year":"2021","unstructured":"Li P, Weng Z, Li P, Hu F, Zhang Y, Guo Z et al (2021) BATF3 promotes malignant phenotype of colorectal cancer through the S1PR1\/p-STAT3\/miR-155-3p\/WDR82 axis. Cancer Gene Ther 28(5):400\u2013412","journal-title":"Cancer Gene Ther"},{"issue":"1","key":"9059_CR22","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/leu.2017.275","volume":"32","author":"K Vrzalikova","year":"2018","unstructured":"Vrzalikova K, Ibrahim M, Vockerodt M, Perry T, Margielewska S, Lupino L et al (2018) S1PR1 drives a feedforward signalling loop to regulate BATF3 and the transcriptional programme of Hodgkin lymphoma cells. Leukemia 32(1):214\u2013223","journal-title":"Leukemia"},{"issue":"3","key":"9059_CR23","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.bcmd.2010.07.011","volume":"45","author":"MS Gonzalez","year":"2010","unstructured":"Gonzalez MS, De Brasi CD, Bianchini M, Gargallo P, Moiraghi B, Bengi\u00f3 R et al (2010) BAX\/BCL-XL gene expression ratio inversely correlates with Disease progression in chronic Myeloid Leukemia. Blood Cells Mol Dis 45(3):192\u2013196","journal-title":"Blood Cells Mol Dis"},{"issue":"355","key":"9059_CR24","doi-asserted-by":"publisher","first-page":"355ra117","DOI":"10.1126\/scitranslmed.aag1180","volume":"8","author":"BZ Carter","year":"2016","unstructured":"Carter BZ, Mak PY, Mu H, Zhou H, Mak DH, Schober W et al (2016) Combined targeting of BCL-2 and BCR-ABL tyrosine kinase eradicates chronic myeloid leukemia stem cells. Sci Transl Med 8(355):355ra117-355ra117","journal-title":"Sci Transl Med"},{"key":"9059_CR25","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1471-2121-14-32","volume":"14","author":"M Brentnall","year":"2013","unstructured":"Brentnall M, Rodriguez-Menocal L, De Guevara RL, Cepero E, Boise LH (2013) Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis. BMC Cell Biol 14:32","journal-title":"BMC Cell Biol"},{"issue":"6","key":"9059_CR26","doi-asserted-by":"publisher","first-page":"a008672","DOI":"10.1101\/cshperspect.a008672","volume":"5","author":"AB Parrish","year":"2013","unstructured":"Parrish AB, Freel CD, Kornbluth S (2013) Cellular mechanisms controlling caspase activation and function. Cold Spring Harb Perspect Biol 5(6):a008672","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"3","key":"9059_CR27","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1046\/j.1365-2141.2002.03468.x","volume":"117","author":"AM Di Bacco","year":"2002","unstructured":"Di Bacco AM, Cotter TG (2002) p53 expression in K562 cells is associated with caspase-mediated cleavage of c-ABL and BCR-ABL protein kinases. Br J Haematol 117(3):588\u2013597","journal-title":"Br J Haematol"},{"key":"9059_CR28","doi-asserted-by":"publisher","first-page":"738301","DOI":"10.1155\/2011\/738301","volume":"2011","author":"Y Lu","year":"2011","unstructured":"Lu Y, Chen G-Q (2011) Effector caspases and Leukemia. Int J Cell Biol 2011:738301","journal-title":"Int J Cell Biol"},{"issue":"3","key":"9059_CR29","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.18632\/oncotarget.23283","volume":"9","author":"G Sodaro","year":"2018","unstructured":"Sodaro G, Cesaro E, Montano G, Blasio G, Fiorentino F, Romano S et al (2018) Role of ZNF224 in c-Myc repression and imatinib responsiveness in chronic Myeloid Leukemia. Oncotarget 9(3):3417","journal-title":"Oncotarget"},{"issue":"1","key":"9059_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-015-0407-0","volume":"14","author":"N Sharma","year":"2015","unstructured":"Sharma N, Magistroni V, Piazza R, Citterio S, Mezzatesta C, Khandelwal P et al (2015) BCR\/ABL1 and BCR are under the transcriptional control of the MYC oncogene. Mol Cancer 14(1):1\u201311","journal-title":"Mol Cancer"},{"key":"9059_CR31","doi-asserted-by":"publisher","first-page":"S114","DOI":"10.1016\/j.exphem.2018.06.080","volume":"64","author":"J Zhu","year":"2018","unstructured":"Zhu J, Sunohara M, Benyoucef A, Brand M (2018) Targeting the process of C-MYC stabilization in chronic myelogenous Leukemia. Exp Hematol 64:S114","journal-title":"Exp Hematol"},{"issue":"1","key":"9059_CR32","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/leu.2017.203","volume":"32","author":"A Lollies","year":"2018","unstructured":"Lollies A, Hartmann S, Schneider M, Bracht T, Wei\u00df AL, Arnolds J et al (2018) An oncogenic axis of STAT-mediated BATF3 upregulation causing MYC activity in classical Hodgkin Lymphoma and anaplastic large cell Lymphoma. Leukemia 32(1):92\u2013101","journal-title":"Leukemia"},{"issue":"2","key":"9059_CR33","first-page":"187","volume":"85","author":"K Gavrilov","year":"2012","unstructured":"Gavrilov K, Saltzman WM (2012) Therapeutic siRNA: principles, challenges, and strategies. Yale J Biol Med 85(2):187","journal-title":"Yale J Biol Med"},{"key":"9059_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-62703-311-4_4","author":"S Petri","year":"2013","unstructured":"Petri S, Meister G (2013) siRNA design principles and off-target effects. Target Identif Valid Drug Discov. https:\/\/doi.org\/10.1007\/978-1-62703-311-4_4","journal-title":"Target Identif Valid Drug Discov"},{"key":"9059_CR35","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3389\/fimmu.2017.00331","volume":"8","author":"Z Meng","year":"2017","unstructured":"Meng Z, Lu M (2017) RNA interference-induced innate immunity, off-target effect, or immune adjuvant? Front Immunol 8:331","journal-title":"Front Immunol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-09059-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-023-09059-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-09059-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T20:33:13Z","timestamp":1738701193000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-023-09059-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,13]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9059"],"URL":"https:\/\/doi.org\/10.1007\/s11033-023-09059-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,13]]},"assertion":[{"value":"23 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All experiments and procedures were conducted in compliance with the ethical principles of Shiraz University of Medical Science, Shiraz, Iran and approved by the regional ethical committee for medical research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethical statement"}}],"article-number":"100"}}